OFFICIAL POSITION STATEMENT: Point-of-Care Bacterial Autofluorescence Imaging in the Assessment and Management of Hard-to-Heal Wounds

Next
Next

RECAP: FDA’s Patient-Focused Drug Development Meeting On Nonhealing Chronic Wounds